BioPharma Services USA has been awarded a 5-year, $20 million contract with the Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA). The contract is to conduct in vivo studies of generic drug products in human subjects over a period of five years, from 2016 through to 2021. “We are very proud to work with the FDA in support of their generic drug programs. This award is a great example of BioPharma’s capabilities as a leading industry e...